AI MARKET SCANNING

Omeros Corp

📅 Next Catalyst: Nov 12, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.34%
MAX GAP RECORD -24.94%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $OMER
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+21.44%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+1.11%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+5.73%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
+2.67%
Mar 31, 2025 Earnings Release 2025-03-31 (AFTER CLOSE)
+11.44%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
+5.49%
Aug 07, 2024 Earnings Release 2024-08-07 (AFTER CLOSE)
-0.48%

VOLATILITY & GAP BIAS

AVG GAP MOVE 8.3%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $OMER

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-07 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 32m +5.69%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗